Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03474692Active Not Recruiting

Virta Health Registry

Role: lead

NCT05516797Not ApplicableCompleted

IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)

Role: collaborator

NCT04807218Not ApplicableCompleted

Virta Intervention in CommuniTies in cOloRado (VICTOR-Pilot)

Role: collaborator

NCT04481724Not ApplicableCompleted

Gamma-linolenic Acid Supplementation Study

Role: lead

NCT02519309Not ApplicableCompleted

Dietary Intervention in Type-2 Diabetes and Pre-Diabetes

Role: lead

All 5 trials loaded